Duloxetine Capsule, Delayed Release
Product Images NDC 80425-0119

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 80425-0119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Duloxetine Dr 60mg Cap Qty 30 Ndc 80425 0119

This is a label for Duloxetine DR 60mg Capsules, which have been packed by a company called "AAdvanced" in a bottle of 30 capsules. The expiration date is listed as 0924 and the product was manufactured by Antapharmal. There is also a lot number of 30DULE and a batch number of 02024.*

FDA Label Image

Duloxetine Dr 60mg Cap Qty 60 Ndc 80425 0119

This is a label for Duloxetine DR 60mg Capsules. No further information is available.*

FDA Label Image

Image 11

This text appears to be presentation of a medical treatment plan for pain management with Duloxetine, a medication used for depression, anxiety and nerve damage caused by diabetes. It also includes a graph of percentage improvement in pain from baseline as a function of time.*

FDA Label Image

Image 2

FDA Label Image

Image 4

The text provides a table illustrating a percentage of patients improved with various doses of duloxetine and placebo. It also displays the percent improvement in pain from baseline. No further information is available.*

FDA Label Image

Image 6

FDA Label Image

Image 7

This appears to be a chart comparing the percentage of patients who saw improvement in pain from a baseline measurement using different treatments. The chart lists Duloxetine taken twice daily, Duloxetine taken once daily, and a placebo. The percentage of patients who saw improvement in pain is shown as 100% for the Duloxetine taken twice daily treatment, and there are visual bars representing the percentage improvement for the other treatments.*

FDA Label Image

Image 8

FDA Label Image

Image 9

This is a description of a medical treatment involving the use of a drug called Duloxetine at a dose of 60/120 mg once daily for patients experiencing pain. The label "Placebo" at the start suggests that this is a comparison study, although there is insufficient information to determine what the comparison is. The final line refers to "Percent Improvement in Pain from Baseline (BOCF)".*

FDA Label Image

Image

FDA Label Image

Image10

This text presents data from a clinical study comparing the effectiveness of a placebo versus a 60 mg dose of duloxetine taken once daily to alleviate pain. The graph displays the percentage of improvement in pain from the baseline at different time points in the study, ranging from 0 to 100. There are some illegible characters and symbols that cannot be determined.*

FDA Label Image

Image3

This is a graph showing the proportion of patients with relapse based on a study of a treatment compared to a placebo. The treatment being studied is Duloxetine. The x-axis shows the time in days from randomization to relapse and the y-axis shows the proportion of patients with relapse.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.